You searched for metabolic diseases - Page 39 of 62

signing contract PORTRAIT IMAGES ASIA BY NONWARIT fi

News and Trends 17 Oct 2016

TxCell lines up another duck in its CAR-Treg campaign

Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up…

October 17, 2016 - 2 minutesmins - By Evelyn Warner

Interview 19 Feb 2018

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

…powerful, very directed, very targeted kind of therapy. Again, we have to be cautious, but if it works, there is a very large panel of diseases we can potentially target….

February 19, 2018 - 9 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 5 Jul 2023

Six biotech companies leading the way in Hong Kong

…certain proteins for the diagnosis of various diseases. Another technology that the biotech focuses on is the BioChip. The BioChip is able to detect a number of respiratory-disease causing pathogens…

July 5, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 2 Nov 2017

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

…autoimmune diseases with high medical need. With the announcement of a €18M Series A, it hopes to take begin moving its candidates into the clinic. It had raised €14M thanks…

November 2, 2017 - 2 minutesmins - By Alex Dale

More News! 20 Nov 2018

Phase I Gives Hope for First Zika Vaccine

…Zika vaccine. In addition, scientists at the US National Institute of Allergy and Infectious Diseases started a Phase II trial of their own Zika vaccine last year. In addition to…

November 20, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Mar 2023

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which…

March 13, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 20 Sep 2022

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

…of the immune system, as it develops innovative drugs for immune-mediated and immuno-oncology diseases. CytoReason’s platform has provided Pfizer with multiple insights in research and development programs across more than…

September 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 4 Jan 2019

Innovative Eye Disease Therapies Move Closer to the Clinic

Oculis has increased its series B fundraising round to CHF35M (€31M) to continue development of its pipeline of topical eye treatments for diseases such as diabetic macular edema. The company…

January 4, 2019 - 2 minutesmins - By Helen Albert

Interview 2 May 2023

Generative AI in novel drug development

…sense. ChatGPT struggles with languages that we don’t have a lot of training data on. Do generative chemistry models also perform poorly in the case of diseases, say rare diseases,…

May 2, 2023 - 4 minutesmins - By Sachin Rawat

News and Trends 12 Apr 2018

British Biotech Raises £29M Round to Fight Lung Disease

…for treating lung diseases including cystic fibrosis, severe asthma and chronic obstructive pulmonary artery disease. In respiratory diseases such as cystic fibrosis, the lungs become congested with mucus, which leads…

April 12, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Mar 2020

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners….

March 20, 2020 - 3 minutesmins - By Jonathan Smith

In Depth 17 Oct 2017

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

…it. Today you can be a severe psoriasis sufferer and live with almost clear skin.” However, Thormann adds, “I think that as in many other diseases, there are two main…

October 17, 2017 - 7 minutesmins - By Diana Kwon

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

TxCell lines up another duck in its CAR-Treg campaign

Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease

Six biotech companies leading the way in Hong Kong

German Biotech Pockets €18M in its Series A to Propel Autoimmune Disease Candidate Forward

Phase I Gives Hope for First Zika Vaccine

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

Innovative Eye Disease Therapies Move Closer to the Clinic

Generative AI in novel drug development

British Biotech Raises £29M Round to Fight Lung Disease

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!